The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
Open accessAbstract
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes global epidemics of a debilitating polyarthritis in humans. As there is a pressing need for the development of therapeutic agents, we screened 230 new mouse anti-CHIKV monoclonal antibodies (MAbs) for their ability to inhibit infection of all three CHIKV genotypes. Four of 36 neutralizing MAbs (CHK-102, CHK-152, CHK-166, and CHK-263) provided complete protection against lethality as prophylaxis in highly susceptible immunocompromised mice lacking the type I IFN receptor (Ifnar(-/-) ) and mapped to distinct epitopes on the E1 and E2 structural proteins. CHK-152, the most protective MAb, was humanized, shown to block viral fusion, and require Fc effector function for optimal activity in vivo. In post-exposure therapeutic trials, administration of a single dose of a combination of two neutralizing MAbs (CHK-102+CHK-152 or CHK-166+CHK-152) limited the development of resistance and protected immunocompromised mice against disease when given 24 to 36 hours before CHIKV-induced death. Selected pairs of highly neutralizing MAbs may be a promising treatment option for CHIKV in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak
Schuffenecker, I., Iteman, I., Michault, A., Murri, S., Frangeul, L., Vaney, M.-C., Lavenir, R., Pardigon, N., Reynes, J.-M., Pettinelli, F., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030263 · Cited by 1,222
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus
Powers, A. M., & Logue, C. H. (2007) · Journal of General Virology · doi:10.1099/vir.0.82858-0 · Cited by 822
Chikungunya Fever: An Epidemiological Review of a Re‐Emerging Infectious Disease
Staples, J. E., Breiman, R. F., & Powers, A. M. (2009) · Clinical Infectious Diseases · doi:10.1086/605496 · Cited by 735
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
Voss, J. E., Vaney, M.-C., Duquerroy, S., Vonrhein, C., Girard-Blanc, C., Crublet, E., Thompson, A., Bricogne, G., & Rey, F. A. (2010) · Nature · doi:10.1038/nature09555 · Cited by 696
Powers, A. M., Brault, A. C., Tesh, R. B., & Weaver, S. C. (2000) · Microbiology · doi:10.1099/0022-1317-81-2-471 · Cited by 653
Chikungunya: a re-emerging virus
Burt, F. J., Rolph, M. S., Rulli, N. E., Mahalingam, S., & Heise, M. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60281-x · Cited by 638
Self-citationCouderc, T., Chrétien, F., Schilte, C., Disson, O., Brigitte, M., Guivel-Benhassine, F., Touret, Y., Barau, G., Cayet, N., Schuffenecker, I., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040029 · Cited by 620
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages
Labadie, K., Larcher, T., Joubert, C., Mannioui, A., Delache, B., Brochard, P., Guigand, L., Dubreil, L., Lebon, P., Verrier, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40104 · Cited by 589
Developments in the CCP 4 molecular-graphics project
Potterton, L., McNicholas, S., Krissinel, E., Gruber, J., Cowtan, K., Emsley, P., Murshudov, G. N., Cohen, S., Perrakis, A., & Noble, M. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904023716 · Cited by 557
Tao, M. H., & Morrison, S. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2595 · Cited by 530
The Fusion Glycoprotein Shell of Semliki Forest Virus
Lescar, J., Roussel, A., Wien, M. W., Navaza, J., Fuller, S. D., Wengler, G., Wengler, G., & Rey, F. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00303-8 · Cited by 518
Akahata, W., Yang, Z.-Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W.-P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2105 · Cited by 515
Self-citationDevelopment of a humanized monoclonal antibody with therapeutic potential against West Nile virus
Oliphant, T., Engle, M., Nybakken, G. E., Doane, C., Johnson, S., Huang, L., Gorlatov, S., Mehlhop, E., Marri, A., Chung, K. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1240 · Cited by 514
Self-citationChikungunya Virus Arthritis in Adult Wild-Type Mice
Gardner, J., Anraku, I., Le, T. T., Larcher, T., Major, L., Roques, P., Schroder, W. A., Higgs, S., & Suhrbier, A. (2010) · Journal of Virology · doi:10.1128/jvi.02603-09 · Cited by 438
Antibody-Mediated Clearance of Alphavirus Infection From Neurons
Levine, B., Hardwick, J. M., Trapp, B. D., Crawford, T. O., Bollinger, R. C., & Griffin, D. E. (1991) · Science · doi:10.1126/science.1658936 · Cited by 361
Structural basis of West Nile virus neutralization by a therapeutic antibody
Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S., & Fremont, D. H. (2005) · Nature · doi:10.1038/nature03956 · Cited by 352
Self-citationStructural changes of envelope proteins during alphavirus fusion
Li, L., Jose, J., Xiang, Y., Kuhn, R. J., & Rossmann, M. G. (2010) · Nature · doi:10.1038/nature09546 · Cited by 328
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Qiu, X., Audet, J., Wong, G., Pillet, S., Bello, A., Cabral, T., Strong, J. E., Plummer, F., Corbett, C. R., Alimonti, J. B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003876 · Cited by 315
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Self-citationA Mouse Model of Chikungunya Virus–Induced Musculoskeletal Inflammatory Disease
Morrison, T. E., Oko, L., Montgomery, S. A., Whitmore, A. C., Lotstein, A. R., Gunn, B. M., Elmore, S. A., & Heise, M. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.018 · Cited by 290
Self-citationNon-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis
Schmaljohn, A. L., Johnson, E. D., Dalrymple, J. M., & Cole, G. A. (1982) · Nature · doi:10.1038/297070a0 · Cited by 220
Mapping the Structure and Function of the E1 and E2 Glycoproteins in Alphaviruses
Mukhopadhyay, S., Zhang, W., Gabler, S., Chipman, P. R., Strauss, E. G., Strauss, J. H., Baker, T. S., Kuhn, R. J., & Rossmann, M. G. (2006) · Structure · doi:10.1016/j.str.2005.07.025 · Cited by 220
Chikungunya: A Potentially Emerging Epidemic?
Thiboutot, M. M., Kannan, S., Kawalekar, O. U., Shedlock, D. J., Khan, A. S., Sarangan, G., Srikanth, P., Weiner, D. B., & Muthumani, K. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000623 · Cited by 214
Infectious Clones of Chikungunya Virus (La Réunion Isolate) for Vector Competence Studies
Tsetsarkin, K., Higgs, S., McGee, C. E., Lamballerie, X. D., Charrel, R. N., & Vanlandingham, D. L. (2006) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2006.6.325 · Cited by 209
Chimeric alphavirus vaccine candidates for chikungunya
Wang, E., Volkova, E., Adams, A. P., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.054 · Cited by 191
Coffey, L. L., & Vignuzzi, M. (2011) · Journal of Virology · doi:10.1128/jvi.01918-10 · Cited by 174
Sun, S., Xiang, Y., Akahata, W., Holdaway, H., Pal, P., Zhang, X., Diamond, M. S., Nabel, G. J., & Rossmann, M. G. (2013) · eLife · doi:10.7554/elife.00435 · Cited by 174
Self-citationSmit, J. M., Bittman, R., & Wilschut, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8476-8484.1999 · Cited by 167
Self-citationMolecular mechanisms of antibody-mediated neutralisation of flavivirus infection
Pierson, T. C., & Diamond, M. S. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000665 · Cited by 166
Self-citationStructure and Interactions at the Viral Surface of the Envelope Protein E1 of Semliki Forest Virus
Roussel, A., Lescar, J., Vaney, M. C., Wengler, G., Wengler, G., & Rey, F. A. (2006) · Structure · doi:10.1016/j.str.2005.09.014 · Cited by 143
Goudsmit, J., Marissen, W. E., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Papaneri, A. B., de Kruif, J., Dietzschold, B., Bakker, A. B. H., & Rupprecht, C. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/500470 · Cited by 121
Roehrig, J. T., Day, J. W., & Kinney, R. M. (1982) · Virology · doi:10.1016/0042-6822(82)90346-4 · Cited by 117
Roehrig, J. T., & Mathews, J. H. (1985) · Virology · doi:10.1016/0042-6822(85)90343-5 · Cited by 114
Lee, C. Y., Kam, Y., Frič, J., Malleret, B., Koh, E. G. L., Prakash, C., Huang, W. Q., Lee, W. W. L., Lin, C., Lin, R. T. P., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002390 · Cited by 106
Neutralizing antiviral antibody responses
Zinkernagel, R. M., Lamarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A. F., McCoy, K. D., Fehr, T. H., Bachmann, M. F., Kalinke, U., & Hengartner, H. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)79001-3 · Cited by 99
Schmaljohn, A. L., Kokubun, K. M., & Cole, G. A. (1983) · Virology · doi:10.1016/0042-6822(83)90124-1 · Cited by 98
Strauss, E. G., Stec, D. S., Schmaljohn, A. L., & Strauss, J. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4654-4664.1991 · Cited by 96
Schilte, C., Buckwalter, M. R., Laird, M. E., Diamond, M., Schwartz, O., & Albert, M. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103185 · Cited by 93
Self-citationBoere, W. A. M., Benaissa-Trouw, B. J., Harmsen, M., Kraaijeveld, C. A., & Snippe, H. (1983) · Journal of General Virology · doi:10.1099/0022-1317-64-6-1405 · Cited by 82
Location of a major antigenic site involved in Ross River virus neutralization
Vrati, S., Fernon, C. A., Dalgarno, L., & Weir, R. C. (1988) · Virology · doi:10.1016/0042-6822(88)90474-6 · Cited by 74
Mathews, J. H., Roehrig, J. T., & Trent, D. W. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.594-600.1985 · Cited by 64
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice
Stanley, J., Cooper, S. J., & Griffin, D. E. (1986) · Journal of Virology · doi:10.1128/jvi.58.1.107-115.1986 · Cited by 63
Prabakaran, M., Prabhu, N., He, F., Hongliang, Q., Ho, H.-T., Jia, Q., TaoMeng, Goutama, M., & Kwang, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005672 · Cited by 62
Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus
Boere, W. A. M., Benaissa-Trouw, B. J., Harmsen, T., Erich, T., Kraaijeveld, C. A., & Snippe, H. (1985) · Journal of Virology · doi:10.1128/jvi.54.2.546-551.1985 · Cited by 58
Davis, N., Pence, D. F., Meyer, W. J., Schmaljohn, A. L., & Johnston, R. E. (1987) · Virology · doi:10.1016/0042-6822(87)90175-9 · Cited by 58
Sindbis Virus-mediated Cell Fusion from Without Is a Two-step Event
Edwards, J., & Brown, D. T. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-2-377 · Cited by 49
Mendoza, Q. P., Stanley, J., & Griffin, D. E. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-12-3015 · Cited by 46
Pence, D. F., Davis, N., & Johnston, R. E. (1990) · Virology · doi:10.1016/0042-6822(90)90184-s · Cited by 35
Wust, C. J., Nicholas, J. A., Fredin, D., Dodd, D. C., Brideau, R. J., Levely, M. E., & Brown, A. (1989) · Virus Research · doi:10.1016/0168-1702(89)90009-9 · Cited by 24
Agapov, E. V., Разумов, И. А., Frolov, I. V., Kolykhalov, A. A., Sv, N., & Loktev, V. B. (1994) · Archives of Virology · doi:10.1007/bf01309462 · Cited by 22
Viral Fitness Can Influence the Repertoire of Virus Variants Selected by Antibodies
Martı́n, V., Perales, C., Dávila, M., & Domingo, E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.077 · Cited by 16
Cited by
Mxra8 is a receptor for multiple arthritogenic alphaviruses
Zhang, R., Kim, A. S., Fox, J. M., Nair, S., Basore, K., Klimstra, W. B., Rimkunas, R., Fong, R. H., Lin, H., Poddar, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0121-3 · Cited by 448
Self-citationNeutralizing human antibodies prevent Zika virus replication and fetal disease in mice
Sapparapu, G., Fernandez, E., Kose, N., Cao, B., Fox, J. M., Bombardi, R. G., Zhao, H., Nelson, C. A., Bryan, A. L., Barnes, T., et al. (2016) · Nature · doi:10.1038/nature20564 · Cited by 408
Self-citationStructural Basis of Zika Virus-Specific Antibody Protection
Zhao, H., Fernandez, E., Dowd, K. A., Speer, S. D., Platt, D. J., Gorman, M. J., Govero, J., Nelson, C. A., Pierson, T. C., Diamond, M. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.020 · Cited by 375
Self-citationA CRISPR screen defines a signal peptide processing pathway required by flaviviruses
Zhang, R., Miner, J. J., Gorman, M. J., Rausch, K., Ramage, H., White, J. P., Zuiani, A., Zhang, P., Fernandez, E., Zhang, Q., et al. (2016) · Nature · doi:10.1038/nature18625 · Cited by 369
Self-citationA genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
Zhu, Y., Feng, F., Hu, G., Wang, Y., Yu, Y., Zhu, Y., Xu, W., Cai, X., Sun, Z., Han, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21213-4 · Cited by 304
Metadata
- Authors
- Pal, P., Dowd, K. A., Brien, J. D., Edeling, M. A., Gorlatov, S., Johnson, S., Lee, I., Akahata, W., Nabel, G. J., Richter, M. K. S., Smit, J. M., Fremont, D. H., Pierson, T. C., Heise, M. T., & Diamond, M. S.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-18
- Volume
- 9
- Issue
- 4
- Pages
- e1003312
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2141231462
- Cited by
- 300
- References
- 51
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.